Cleveland-Cliffs Q1 2026 Earnings: Metrics Review Highlights Ongoing Turnaround Challenges

What happened

Cleveland-Cliffs reported Q1 2026 earnings, with a Zacks article comparing key metrics to Wall Street estimates and year-ago results, offering insight into the quarter's performance. The DeepValue report details a fragile recovery, marked by sequential EBITDA improvement from Q1 to Q3 2025 but persistent negative operating cash flow and high net debt of $7.7 billion. Despite management's claims of cost savings and auto contract stability, the earnings likely reveal that underlying cash generation remains weak, failing to address leverage concerns. Investors must look beyond optimistic filings, as propaganda around synergies and tariff benefits masks the cyclical risks and dependence on favorable macro conditions. Overall, CLF's position is still precarious, with the turnaround hinging on elusive sustained positive free cash flow.

Implication

The earnings metrics suggest modest progress on EBITDA, but negative operating cash flow persists, undermining the turnaround thesis and keeping net debt elevated. High interest expenses from recent debt issuances continue to pressure net income, limiting near-term earnings power despite tariff and auto contract tailwinds. Without a clear path to self-funded deleveraging, the balance sheet remains a significant overhang, increasing the risk of dilution or asset sales at distressed prices. Investors should maintain a 'WAIT' stance, as the stock's valuation at $14.11 already assumes a successful recovery that is not yet supported by fundamentals. Monitoring upcoming quarters for sustained positive cash flow and net debt reduction is critical to reassess the investment case.

Thesis delta

The Q1 2026 earnings report does not materially alter the investment thesis; CLF remains in a 'WAIT' phase with low conviction due to ongoing negative cash flow and high leverage. Any incremental improvement in metrics is overshadowed by the lack of progress on deleveraging, keeping downside risks elevated. Investors should continue to prioritize evidence of sustained positive operating cash flow before considering an upgrade to a potential buy.